| GeneLibs

题目:: Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms.
作者:: Wheler(Jennifer J),Parker(Barbara A),Lee(Jack J),Atkins(Johnique T),Janku(Filip),Tsimberidou(Apostolia M),Zinner(Ralph),Subbiah(Vivek),Fu(Siqing),Schwab(Richard),Moulder(Stacy),Valero(Vicente),Schwaederle(Maria),Yelensky(Roman),Miller(Vincent A),Stephens(M Philip J),Meric-Bernstam(Funda),Kurzrock(Razelle)
状态:: 发布时间2014-06-09 , 更新时间 2016-12-06
期刊:: Oncotarget
摘要:: Our analysis of the tumors of 57 women with metastatic breast cancer with next generation sequencing (NGS) demonstrates that each patient's tumor is unique in its molecular fingerprint. We observed 216 somatic aberrations in 70 different genes, including 131 distinct aberrations. The most common gene alterations (in order of decreasing frequency) included: TP53, PIK3CA, CCND1, MYC, HER2 (ERBB2), MCL1, PTEN, FGFR1, GATA3, NF1, PIK3R1, BRCA2, EGFR, IRS2, CDH1, CDKN2A, FGF19, FGF3 and FGF4. Aberrations included mutations (46%), amplifications (45%), deletions (5%), splices (2%), truncations (1%), fusions (0.5%) and rearrangements (0.5%), with multiple distinct variants within the same gene. Many of these aberrations represent druggable targets, either through direct pathway inhibition or through an associated pathway (via 'crosstalk'). The 'molecular individuality' of these tumors suggests that a customized strategy, using an "N-of-One" model of precision medicine, may represent an optimal approach for the treatment of patients with advanced tumors.
语言:: eng
DOI:: 10.18632/oncotarget.1946

文献库文献相关信息

DataTable pData

联系方式

微信公众号

文献库 文献相关信息

DataTable pData

联系方式

微信公众号

文献库文献相关信息